Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04227106 |
|---|---|
| Brief Title: | Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) |
| First Submitted : | January 10, 2020 |
| First Submitted that Met QC Criteria : | January 10, 2020 |
| First Posted : | January 13, 2020 |
| Last Update Submitted that Met QC Criteria : | December 2, 2022 |
| Last Update Posted : | December 5, 2022 |